Healthcare -
Biotechnology - NASDAQ - US
$ 19.03
4.62 %
$ 14 B
Market Cap
-82.74
P/E
SMMT - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities SMMT - Summit Therapeutics Inc.
-588 M
LAST VALUE
-4282.73%
2 YEAR CAGR
-327.74%
5 YEAR CAGR
-136.91%
10 YEAR CAGR